Wales updates strategy to improve respiratory health

Wales updates strategy to improve respiratory health

January 22 2018 An updated respiratory health plan for Wales has been published, taking forward...

GPs urged to request blood test for patients with one or more symptoms of blood cancer

GPs urged to request blood test for patients with one or more symptoms of blood cancer

January 19 2018 A new parliamentary report is recommending that GPs should immediately request a...

Flu consultations increase 78% in a week

Flu consultations increase 78% in a week

January 15 2018 GPs saw over 21,700 cases of patients with influenza-like illness in the first...

New COPD pathway launched

New COPD pathway launched

January 12 2018 NHS RightCare has set out the core components of an optimal service for people...

MHRA warns of confusion over drug names and potential for errors

MHRA warns of confusion over drug names and potential for errors

January 11 2018 Healthcare professionals are being asked to be extra vigilant when prescribing or...

  • Wales updates strategy to improve respiratory health

    Wales updates strategy to improve respiratory health

    Monday, 22 January 2018 15:04
  • GPs urged to request blood test for patients with one or more symptoms of blood cancer

    GPs urged to request blood test for patients with one or more symptoms of blood cancer

    Friday, 19 January 2018 17:45
  • Flu consultations increase 78% in a week

    Flu consultations increase 78% in a week

    Monday, 15 January 2018 10:57
  • New COPD pathway launched

    New COPD pathway launched

    Friday, 12 January 2018 14:53
  • MHRA warns of confusion over drug names and potential for errors

    MHRA warns of confusion over drug names and potential for errors

    Thursday, 11 January 2018 12:40

a scottish flag image cbOctober 27 2017

Scottish ministers have agreed to allow women to use misoprostol at home to terminate an early pregnancy, having taken mifepristone at a clinic.

An amendment to the regulations approves the home of a pregnant woman who is undergoing treatment to terminate a pregnancy as a suitable place where that treatment can occur, providing that the pregnant woman has:

  • attended a clinic where she has been prescribed the combination of mifepristone and misoprostol to terminate the pregnancy; and
  • taken mifepristone at that clinic and wants to carry out the treatment at home.

The procedure is approved for women are up to 9 weeks and 6 days into gestation.

The document introducing the regulatory change, which came into effect on October 27 2017, says that “evidence has clearly demonstrated that early medical discharge with at home self-administration of misoprostol is a safe method of abortion, with no higher risk of complications than medical abortions as a day case.

“This offers additional choice to women requesting an abortion and, in addition to practical and logistical benefits, enables women to complete treatment in an environment where they feel most comfortable.”

It sets out inclusion criteria, contra-indications, cautions in use, and the procedure for using the drugs.

While the mifepristone has to be given at the clinic, the woman will be given a ‘take home’ pack of misoprostol tablets. “Traditional administration has been by the vaginal route, but sublingual route and buccal routes are as effective and the patient should be advised on how to self-administer by the preferred route,” says the guidance. Ordinarily, the misoprostol should be taken 24-48 hours after the mifepristone.

Link:
Scottish Government announcement ‘Abortion: improvement to existing services: approval for Misoprostol to be taken at home’                  

Professional News

January 22 2018 An updated respiratory health plan for Wales has been published, taking forward the national strategy for the next three years.